Free Trial

Axon Enterprise, Inc. (NASDAQ:AXON) Position Cut by HighTower Advisors LLC

Axon Enterprise logo with Aerospace background
Remove Ads

HighTower Advisors LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 21.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,251 shares of the biotechnology company's stock after selling 18,524 shares during the period. HighTower Advisors LLC owned about 0.09% of Axon Enterprise worth $39,968,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Assetmark Inc. lifted its stake in Axon Enterprise by 4.2% in the 3rd quarter. Assetmark Inc. now owns 5,315 shares of the biotechnology company's stock valued at $2,124,000 after buying an additional 214 shares in the last quarter. Atria Investments Inc increased its holdings in shares of Axon Enterprise by 31.4% during the 3rd quarter. Atria Investments Inc now owns 3,901 shares of the biotechnology company's stock worth $1,559,000 after buying an additional 933 shares during the last quarter. Los Angeles Capital Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth $709,000. Versor Investments LP purchased a new position in shares of Axon Enterprise in the 3rd quarter worth $651,000. Finally, Apollon Wealth Management LLC boosted its holdings in Axon Enterprise by 11.3% in the third quarter. Apollon Wealth Management LLC now owns 1,304 shares of the biotechnology company's stock valued at $521,000 after acquiring an additional 132 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on AXON shares. Needham & Company LLC restated a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target on the stock. Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Finally, The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus target price of $604.67.

Remove Ads

Read Our Latest Stock Report on Axon Enterprise

Insider Activity

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now owns 124,243 shares of the company's stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, President Joshua Isner sold 1,291 shares of the firm's stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the transaction, the president now owns 181,892 shares in the company, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,146 shares of company stock worth $2,623,157. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Down 0.3 %

AXON traded down $1.44 during trading on Monday, hitting $554.82. The company had a trading volume of 664,384 shares, compared to its average volume of 863,644. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $42.51 billion, a PE ratio of 143.36, a P/E/G ratio of 5.17 and a beta of 1.12. The business has a 50-day moving average of $593.42 and a 200-day moving average of $536.68.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads